Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_assertion description "[Interestingly, the scope of S1P receptor therapy reported here is likely to extend beyond influenza virus infection and could prove useful for the treatment of multiple maladies like other viral infections and autoimmune diseases where the host's inflammatory response is a major component in the disease process.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_assertion evidence source_evidence_literature NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_assertion SIO_000772 21901448 NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_assertion wasDerivedFrom befree-20150227 NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_assertion wasGeneratedBy ECO_0000203 NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.
- befree-20150227 importedOn "2015-02-27" NP802604.RAddSgmrVp2ok7K-lr7S6nW5k621a4T8F0LzCNWAwwn2c130_provenance.